Tuesday, 6 August 2013
Views sought on draft NICE guidance that says breast cancer drug is not value for money
Views sought on draft NICE guidance that says breast cancer drug is not value for money The NHS is to be advised that it shouldn't routinely provide the drug pertuzumab as a treatment for a type of advanced breast cancer, according to draft guidance from NICE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment